9UP7

anti-HPV18 E7 monoclonal antibody

Summary for 9UP7

• Entry DOI: 10.2210/pdb9up7/pdb
• Descriptor: Heavy chain of the anti-HPV18 E7 monoclonal antibody 17F2, Light chain of the anti-HPV18 E7 monoclonal antibody 17F2 (3 entities in total)
• Functional Keywords: monoclonal antibody, immune system
• Biological source: Mus musculus; More
• Total number of polymer chains: 4
• Total formula weight: 94405.09

Authors

Feng, H.,Tingting, L.,Ying, G.,Shaowei, L. (deposition date: 2025-04-27, release date: 2026-01-21, Last modification date: 2026-08-05)

Primary citation

Han, F.,Guo, X.y.,Cui, L.y.,Zhang, M.x.,Zeng, Y.r.,Wang, G.q.,Li, J.j.,Chi, X.,Jiang, M.x.,Xiong, Y.t.,Zhou, L.z.,Zheng, Q.b.,Yu, H.,Zhang, J.,Li, T.t.,Gu, Y.,Xia, N.s.,Li, S.
An mRNA-encoded scFv antibody targeting the helix-alpha 3 of HPV18 E7 oncoprotein as a novel antiviral strategy.
Mbio, 17:e0262725-e0262725, 2026

PubMed Abstract: Despite the availability of prophylactic vaccines, human papillomavirus (HPV) infection remains the leading viral cause of cancer worldwide. The HPV E7 oncoprotein is a key factor in cancer progression by degrading host tumor suppressor proteins, thus offering a promising target for antiviral therapy. In this study, we screened a panel of high-affinity antibodies against HPV18 E7. Through evaluation of their cytotoxic effects in HPV18-positive HeLa cells, incorporating the structure of antibodies and the structural simulation of complexes, we identified the α3 helix of the HPV18 E7 protein and its adjacent groove as a novel and effective antiviral epitope. The candidate antibody 17F2 showed efficacy in inhibiting cell proliferation and tumor formation when transfected into HeLa cells as a single-chain variable fragment (scFv). To directly assess the efficacy of the antibody and enhance the accessibility of antibody drugs, we employed an mRNA platform for scFv delivery. This approach significantly inhibited the growth of HPV18-positive tumors in the immunodeficient mouse models. Our study identifies the α3 helix of HPV18 E7 as a viable antiviral target and provides proof of concept for mRNA-encoded scFv antibodies as a novel and effective strategy to neutralize viral oncoproteins in the treatment of HPV-related cancers.

PubMed: 41627058
DOI: 10.1128/mbio.02627-25

Experimental method

X-RAY DIFFRACTION (2.1 Å)